Endothelin-1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation

Heart Rhythm

Volumn 6, Issue 6, 2009, Pages 725-730

  Nakazawa, Yuko ^a   Ashihara, Takashi ^a   Tsutamoto, Takayoshi ^a   Ito, Makoto ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Atrial fibrillation; Endothelin 1; Neurohumoral factor; Predictive factor; Pulmonary vein isolation; Recurrence; Remodeling

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; RENIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY VEIN; RECURRENT DISEASE;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY VEINS; RECURRENCE; TIME FACTORS;

EID: 65649131214     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.02.027     Document Type: Article

References (33)

1. Haïssaguerre M., Jaïs P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
2. Pappone C., Rosanio S., Oreto G., et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102 (2000) 2619-2628
3. Oral H., Scharf C., Chugh A., et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108 (2003) 2355-2360
4. Verma A., Wazni O.M., Marrouche N.F., et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 45 (2005) 285-292
5. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
6. Ono K., Tsujimoto G., Sakamoto A., et al. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 370 (1994) 301-304
7. Duru F., Barton M., Lüscher T.F., et al. Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?. Cardiovasc Res 49 (2001) 272-280
8. 2+ signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 541 (2002) 395-409
9. 2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate (IP3)-receptor type 2-deficient mice. Circ Res 96 (2005) 1274-1281
10. Lüscher T.F., and Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102 (2000) 2434-2440
11. Burrell K.M., Molenaar P., Dawson P.J., et al. Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670. J Pharmacol Exp Ther 292 (2000) 449-459
12. Wijffels M.C., Kirchhof C.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
13. Lévy S., Camm A.J., Saksena S., et al. International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 14 (2003) 443-445
14. Murray J.A., Kennedy J.W., Figley M.M., et al. Quantitative angiocardiography: II. The normal left atrial volume in man. Circulation 37 (1968) 800-804
15. Mabuchi N., Tsutamoto T., Maeda K., et al. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 64 (2000) 765-777
16. Wozakowska-Kapłon B., and Opolski G. Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol 41 (2003) 1716-1720
17. Goette A., Hoffmanns P., Enayati W., et al. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. Am J Cardiol 88 (2001) 906-909
18. Tsutamoto T., Wada A., Maeda Y., et al. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol 23 (1994) 1427-1433
19. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
20. Wada A., Tsutamoto T., Matsuda Y., et al. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation 89 (1994) 2232-2240
21. Tsutamoto T., Wada A., Maeda K., et al. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure. Am Heart J 134 (1997) 910-916
22. Gerstenfeld E.P., Dixit S., Callans D., et al. Utility of exit block for identifying electrical isolation of the pulmonary veins. J Cardiovasc Electrophysiol 13 (2002) 971-979
23. Chen M.S., Marrouche N.F., Khaykin Y., et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 43 (2004) 1004-1009
24. Katritsis D.G., Toumpoulis I.K., Giazitzoglou E., et al. Latent arterial hypertension in apparently lone atrial fibrillation. J Interv Card Electrophysiol 13 (2005) 203-207
25. Yamada T., Murakami Y., Okada T., et al. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace 9 (2007) 770-774
26. Yue L., Feng J., Gaspo R., et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81 (1997) 512-525
27. Van Wagoner D.R., Pond A.L., Lamorgese M., et al. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res 85 (1999) 428-436
28. Redpath C.J., Rankin A.C., Kane K.A., et al. Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol 40 (2006) 717-724
29. Fujisaki H., Ito H., Hirata Y., et al. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest 96 (1995) 1059-1065
30. van Wamel A.J., Ruwhof C., van der Valk-Kokshoom L.E., et al. The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy. Mol Cell Biochem 218 (2001) 113-124
31. Li D., Shinagawa K., Pang L., et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104 (2001) 2608-2614
32. Hocini M., Jaïs P., Sanders P., et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation 112 (2005) 3688-3696
33. O'Neill M.D., Jaïs P., Takahashi Y., et al. The stepwise ablation approach for chronic atrial fibrillation-evidence for a cumulative effect. J Interv Card Electrophysiol 16 (2006) 153-167